Market Research Logo

Direct-to-Consumer (DTC) Genetic Testing

Direct-to-Consumer (DTC) Genetic Testing

This report analyzes the worldwide markets for Cardiology IT Workflow Solutions in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.  Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as -

 Agfa HealthCare NV
Biomedix
Carestream Health
Circle Cardiovascular Imaging, Inc.
Digisonics, Inc.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
Genetic Testing: A Synopsis
Direct-to-Consumer (DTC) Genetic Testing: An Overview
Market Overview
Major Factors Impacting DTC Genetic Testing Market
Consumers Self-Managing Treatments: The New Trend
Authorities Grappling With Setting Appropriate Regulations for DTC Genetic Testing
Changing Landscape of DTC Genetic Testing
Regulations to Determine Market Viability
Potential Benefits Outweigh Concerns
DTC Genetic Testing: High Potential Benefits, But Concerns Persist
Quality Assurance
Confidentiality of Genetic Information
Price and Related Services
Greater Chances of Misinterpretation
Regulatory Headwinds and Data Paucity Impacting DTC Genetic Testing Market
Despite Progress in DTC Genetic Testing Regulations, Concerns Still Linger
Transparency of Data: Bugbear of DTC Genetic Testing Companies
The Contextual Privacy Conundrum
Increasing Adoption Raises the Threat of Data Breach
DTC Genetic Testing Companies – An Unregulated Lot
Association for Molecular Pathology v. Myriad Genetics, Inc. Ruling Removes Potential Barriers for DTC Genetic Testing Companies
Competitive Scenario
Recent Transactions in DTC Genetics Testing Market
2. OVERVIEW OF DTC GENETIC TESTING BY MODALITY
Non-Invasive Prenatal Genetic Testing – A Resounding Success
DTC Genetic Testing in Ophthalmology – Seeking an Easy Way Out
DTC Genetic Testing in Cystic Fibrosis
3. DIRECT-TO-CONSUMER GENETIC TESTING: AN OVERVIEW
DTC Genetic Testing – An Introduction
Process of DTC Genetic Testing
Preface to Genetic Testing
Genetic Testing and Applications
Advantages of DTC Genetic Testing
Risks Involved in DTC Genetic Testing
Interpretation of Results
Positive Tested Result
Negative Tested Result
Select DTC Genetic Testing Companies and Tests Offered
4. PRODUCTS INNOVATIONS/INTRODUCTIONS
MyHeritage Introduces MyHeritage DNA Services to Help Uncover Familial Ethnicity and History
23andMe Reintroduces Genetic Testing Kit for Fewer Diseases in US Market
LabCorp Launches VistaSeq® Hereditary Cancer Panel Focusing on Commonly Diagnosed Cancers
Quest Diagnostics and Inserm Launch BRCA Share™, a Datashare Initiative with Open Access to BRCA1 and BRCA2 Genetic Data
23andMe Rolls Out Personal Genome Service in the UK
5. RECENT INDUSTRY ACTIVITY
Color Genomics Raises US$45 million in Series B Funding Led by General Catalyst
Human Longevity Closes US$220 million Series B Funding
Silver Lakes and GIC Acquire Minority Stake in Ancestry.com
23andMe Bags FDA Approval for Personal Genome Service®, a DTC Genetic Test for Bloom Syndrome
23andMe Completes US$ 115 million Series E Financing
Angel Investors Pump in US$1.1 million into Mapmygenome in Pre-series A Funding
6. FOCUS ON SELECT PLAYERS
23andMe, Inc. (USA)
Ancestry.com, LLC (USA)
Any Lab Test Now (USA)
Color Genomics, Inc. (USA)
Counsyl, Inc. (USA)
Direct Laboratory Services, LLC (USA)
Gene by Gene, Ltd. (USA)
Laboratory Corporation of America® Holdings (USA)
Mapmygenome India Limited (India)
Positive Bioscience, Inc. (India)
Quest Diagnostics, Inc. (USA)
Request A Test, Ltd. (USA)
Sonora Quest Laboratories LLC (USA)
Xcode Life Sciences (India)
7. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
Table 2: World 9-Year Perspective for Direct-to-Consumer (DTC) Genetic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2014, 2016 & 2022 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A. Market Analysis
Market Overview
Paradigm Shift Amongst Consumers Spurring DTC Genetic Testing Market
DTC Genetic Testing – A Highly Competitive Market
Regulatory Scenario in US DTC Genetic Testing Market
An Overview
Regulatory Authorities Involved in Regulating DTC Genetics Testing Market
The Genetic Information Nondiscrimination Act (GINA)
Maryland House to Debate on Bill Allowing DTC Genetic Testing
Strategic Corporate Developments
Product Launches
Select Players
B. Market Analytics
Table 3: US Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
2. CANADA
Market Analysis
Table 4: Canadian Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022
3. JAPAN
Market Analysis
Table 5: Japanese Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Current and Future Analysis
DTC Genetic Testing in Europe – A Mixed Bag
Product Launch
B. Market Analytics
Table 6: European Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
A. Market Analysis
Current and Future Analysis
Strategic Corporate Development
Select Players
B. Market Analytics
Table 7: Asia-Pacific Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
6. REST OF WORLD
A. Market Analysis
Current and Future Analysis
Product Launch
B. Market Analytics
Table 8: Rest of World Recent Past, Current & Future Analysis for Direct-to-Consumer (DTC) Genetic Testing Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2022 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 41 (including Divisions/Subsidiaries - 43)
The United States (28)
Canada (3)
Europe (8)
- The United Kingdom (4)
- Rest of Europe (4)
Asia-Pacific (Excluding Japan) (3)
Middle East (1)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report